Beijing Wantai is a manufacturer of infectious disease diagnostics. It operates domestic and international diagnostic test businesses in the fields of human infectious diseases and screening of blood donors. Its customers are blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. Innovax is a separate division of Wantai that focuses on the development and commercialization of recombinant vaccines. Innovax's flagship product Hecolin, is the world's first launched Hepatitis E vaccine. Its production facilities are GMP, ISO9001 and ISO13485 certified. Founded in 1991, Beijing Wantai is headquartered in Beijing, China.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women��s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer��s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Virginia Tech Intellectual Properties, Inc. handles, protects and licenses technologies developed by the faculty, staff and students. It facilitates the licensing of technology to companies, encourages new faculty startup ventures, works with publishers and distributors of software, and supports the transfer of research and knowledge to other universities, research institutes and companies. The company was founded in 1985 and is headquartered in Blacksburg, VA.

Panacea Biotec is an Innovation driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars. Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited with a commitment to make Innovative Products Affordable and Accessible to the masses. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd. Panacea Biotec is witnessing a period of expansion across every aspect of their business from innovative products to customers in market, from manufacturing to regulatory approvals and thereby laying the foundation for translation of their vision in becoming greatest, largest and most admired biotechnology company in the World by 2020. Ardent Research and Development efforts have always been a great strength of Panacea Biotec. The main research areas are New Chemical Entities (NCE), New Biological Entities (NBE) Novel Drug Delivery System (NDDS) based pharmaceutical formulations, Novel peptides & human monoclonal antibodies and Vaccine development. The company has developed four distinguished, ultra-modern, state-of-art R&D centres in different locations, having internal capabilities for constant research, with over 300 highly professional and skilled scientists engaged in various aspects of research.

Novavax is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax recently initiated the development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, with Phase 1 clinical trial results expected in July 2020. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’s proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline; and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.

Shanghai Academy of Agricultural Science is a private company headquartered in Shanghai, China, that provides agricultural research services.

Xiamen Innovax Biotech Co., Ltd. manufactures vaccines and diagnostic reagents. It focuses on research and development, manufacturing, marketing of vaccine, diagnosis kit and medical equipment. The company was founded in 2005 and is headquartered in Xiamen, China.

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Qingdao Yebio Bioengineering Co. Ltd. is a Chinese private company located in Qingdao. The firm engages in research and development, production and distribution of veterinary bioproducts for animal disease prevention, diagnosis and treatment.

China Inspection Science and Technology (Beijing) Group Co., Ltd., established on 2018-12-29, Business scope includes biotechnology,medicine,pesticide,veterinary medicine,food,biological reagent,chemical reagent,Technology development of research materials,technical consulting,Technology Promotion,technology transfer,Technical testing,Technical Services;market survey;health management,Health Advisory(Except for medical treatment activities subject to approval);copyright agent;Sales instrumentation;Import and export,Agent import and export,Technology Import and Export;software development;IC Design;Information system integration service;internet data service(Data Centers in Internet Data Services,PUEvalue in1.4Except for the above cloud computing data centers);Information processing and storage support services(Data centers in information processing and storage support services,PUEvalue in1.4Except for the above cloud computing data centers);Certification Services.(Enterprises independently choose operating projects according to law,Carry out business activities;Certification services and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Blue Cross Biopharmaceutical (Beijing) Co., Ltd., established on 2002-08-30, The scope of business includes the production of biological products,genetically engineered product;Provide technical consultation and technical services for self-produced products;Sell ​​self-produced products;Production2002Catalog:Class III:III-6840In vitro diagnostic reagents,Class II:II-6840In vitro diagnostic reagents,2017Catalog:Class II:II-22-04Fluorescence Immunochromatography Analyzer.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production2002Catalog:Class III:III-6840In vitro diagnostic reagents,Class II:II-6840In vitro diagnostic reagents,2017Catalog:Class II:II-22-04Fluorescence immunochromatography analyzer and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Applied Biological Technologies Co., Ltd. is a company headquartered in Beijing, China. The firm manufactures s analytical tools and instruments.

Suzhou Municipal Hospital is a private company headquartered in Suzhou, China, that operates as a optical goods stores.

Yangshengtang Co., Ltd. engages in the management of pharmaceutical and food products. Its business activities include road cargo transportation, catering services, product packaging design, real estate development, housing rental services, business management consulting, and marketing planning services. It sells cosmetics, clothing, furniture, paper, office equipment, electronic products, communication equipment, agricultural and fishery products, and chemical products. The company was founded on March 12, 1993 and is headquartered in Hangzhou, China.